SG11201809049UA - Enhanced gene delivery methods - Google Patents

Enhanced gene delivery methods

Info

Publication number
SG11201809049UA
SG11201809049UA SG11201809049UA SG11201809049UA SG11201809049UA SG 11201809049U A SG11201809049U A SG 11201809049UA SG 11201809049U A SG11201809049U A SG 11201809049UA SG 11201809049U A SG11201809049U A SG 11201809049UA SG 11201809049U A SG11201809049U A SG 11201809049UA
Authority
SG
Singapore
Prior art keywords
gene delivery
delivery methods
enhanced gene
enhanced
methods
Prior art date
Application number
SG11201809049UA
Other languages
English (en)
Inventor
Paul Finnegan
Claude Davis
Michael Ginsberg
Daniel Nolan
Original Assignee
Angiocrine Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiocrine Bioscience Inc filed Critical Angiocrine Bioscience Inc
Publication of SG11201809049UA publication Critical patent/SG11201809049UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201809049UA 2016-04-15 2017-04-17 Enhanced gene delivery methods SG11201809049UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662323476P 2016-04-15 2016-04-15
US201662403110P 2016-10-01 2016-10-01
PCT/US2017/027884 WO2017181168A1 (en) 2016-04-15 2017-04-17 Enhanced gene delivery methods

Publications (1)

Publication Number Publication Date
SG11201809049UA true SG11201809049UA (en) 2018-11-29

Family

ID=60041985

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201809049UA SG11201809049UA (en) 2016-04-15 2017-04-17 Enhanced gene delivery methods

Country Status (11)

Country Link
US (1) US20190127760A1 (nl)
EP (1) EP3442544B1 (nl)
JP (1) JP7080184B2 (nl)
KR (1) KR102428606B1 (nl)
CN (1) CN109475582A (nl)
AU (1) AU2017248848B2 (nl)
CA (1) CA3021090A1 (nl)
IL (1) IL262310B2 (nl)
RU (1) RU2018139201A (nl)
SG (1) SG11201809049UA (nl)
WO (1) WO2017181168A1 (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018052948A1 (en) 2016-09-13 2018-03-22 Angiocrine Bioscience, Inc. Blood-brain barrier comprising engineered endothelial cells
CN110075319A (zh) * 2019-04-29 2019-08-02 白涛 一种抗遗传病生物导弹
AU2021297353A1 (en) * 2020-06-25 2023-02-02 Angiocrine Bioscience, Inc. Endothelial cells for mitigation of chemotherapy-induced toxicity
WO2023081277A1 (en) * 2021-11-03 2023-05-11 Memorial Sloan-Kettering Cancer Center Epigenetic targets in clonal hematopoiesis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002319780A1 (en) * 2001-08-06 2003-02-24 Bresagen, Ltd. Alternative compositions and methods for the culture of stem cells
WO2006030442A2 (en) * 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
WO2008089442A2 (en) * 2007-01-18 2008-07-24 Western Forms, Inc. Lightweight crane-set forming panel
US8465732B2 (en) * 2007-01-19 2013-06-18 Cornell Research Foundation, Inc. Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
EP2946007B1 (en) * 2013-01-15 2019-04-10 Cornell University Reprogramming of human endothelium into hematopoietic multi-lineage progenitors by defined factors
MX366900B (es) * 2013-03-13 2019-07-30 Wisconsin Alumni Res Found Métodos y materiales para diferenciación hematoendotelial de células germinales pluripotentes humanas bajo condiciones definidas.
US9790393B2 (en) 2013-03-13 2017-10-17 Cabot Corporation Coatings having filler-polymer compositions with combined low dielectric constant, high resistivity, and optical density properties and controlled electrical resistivity, devices made therewith, and methods for making same
CA2926078C (en) * 2013-10-17 2021-11-16 Sangamo Biosciences, Inc. Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

Also Published As

Publication number Publication date
US20190127760A1 (en) 2019-05-02
AU2017248848A1 (en) 2018-11-22
JP7080184B2 (ja) 2022-06-03
EP3442544B1 (en) 2024-05-29
EP3442544A4 (en) 2020-01-01
CN109475582A (zh) 2019-03-15
IL262310B1 (en) 2024-02-01
AU2017248848B2 (en) 2022-12-08
JP2019511238A (ja) 2019-04-25
KR20180133484A (ko) 2018-12-14
WO2017181168A1 (en) 2017-10-19
EP3442544A1 (en) 2019-02-20
RU2018139201A3 (nl) 2020-11-13
IL262310B2 (en) 2024-06-01
KR102428606B1 (ko) 2022-08-02
CA3021090A1 (en) 2017-10-19
RU2018139201A (ru) 2020-05-15
IL262310A (en) 2018-11-29

Similar Documents

Publication Publication Date Title
HK1252836A1 (zh) 水凝膠藥物遞送
IL284577A (en) Garden healing
ZA201604874B (en) Rna-guided gene drives
HK1252168A1 (zh) 基因構建體
HK1249034A1 (zh) 遞送媒介物
GB201407322D0 (en) Gene therapy
HK1250370A1 (zh) 基於硼替佐米的遞送系統
IL249254A0 (en) Gene expression system
IL262310A (en) Advanced methods of gene insertion
IL257500A (en) Altered cullin1 gene
GB201705955D0 (en) Delivery method
GB201513151D0 (en) Functional gene replacement therapy
IL263085A (en) Garden healing
GB201507125D0 (en) Gene delivery
GB201616821D0 (en) Gene therapy
GB201612105D0 (en) Gene therapy
GB201612104D0 (en) Gene therapy
GB201522636D0 (en) Delivery system
GB201522291D0 (en) Delivery vehicle
HK1206556A2 (en) Information delivery method
GB201405197D0 (en) Delivery suite- whelping system
AU2015900021A0 (en) Continuous delivery technique
HU4501U (en) Delivery slip